Related Experiment Videos
Patterns of antidepressant use in community practice
G E Simon1, M VonKorff, E H Wagner
1Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, Washington 98101-1448.
General Hospital Psychiatry
|November 1, 1993
Summary
Patients treated by psychiatrists and with newer antidepressants were more likely to receive intensive antidepressant treatment. Newer medications may offer benefits but come with higher costs, requiring careful consideration.
Area of Science:
- Pharmacology
- Psychiatry
- Health Services Research
Background:
- Antidepressant treatment patterns vary between primary care and specialist settings.
- Understanding adherence and dosage is crucial for effective depression management.
Purpose of the Study:
- To compare antidepressant treatment intensity between primary care physicians and psychiatrists.
- To evaluate the impact of newer antidepressants on treatment duration and dosage.
Main Methods:
- Analysis of computerized pharmacy records from a large health maintenance organization.
- Examination of prescription refill data to determine treatment duration and dosage achievement.
- Comparison of treatment patterns based on physician specialty and antidepressant drug class.
Main Results:
- Patients treated by psychiatrists were more likely to continue medication longer and reach adequate doses compared to primary care patients.
- Newer antidepressants, particularly fluoxetine, were associated with significantly longer treatment durations and higher achievement of adequate doses.
- Psychiatrists were more likely to prescribe newer antidepressants, explaining a portion of the observed differences between specialties.
Conclusions:
- Antidepressant treatment appears more intensive than previously reported, especially in primary care, with newer drugs showing better adherence and dosing.
- While newer antidepressants may have advantages like better tolerability, their higher cost necessitates a balance with clinical benefits.
- Observational data suggest potential selection bias, and further research is needed to confirm the advantages of newer antidepressant medications.